Advanced search
Publication Cover
Näringsforskning Volume 45, 2001 - Issue 1
Journal homepage
912
Views
13
CrossRef citations to date
0
Altmetric
Review Articles

Prebiotics and human health: The state-of-the-art and future perspectives

Patricia L ConwaySchool of Microbiology and Immunology, The University of New South Wales, UNSW Sydney NSW 2052, Australia. E-mail: [email protected]View further author information
, PhD
Pages 13-21 | Published online: 13 Dec 2016

  • Metchnikoff E. The prolongation of life. 1st ed. New York: Putnam Sons, 1908.
  • Gibson GR, Roberfroid MB: Dietary modulation of the human colonic microbiota-introducing the concept of prebiotics. J Nutr 1995: 125: 1401–12.
  • Conway PL: Acquisition and Succession of the gut microflora. In: The gastrointestinal microflora eds. Mackie R.l, White BA, Isaacson RE: New York: International Thomson Publishing. 1996;2,pp. 3–38.
  • Roberfroid MB: Prebotics and Synbiotics - Concepts and Nutritional Properties. Br J Nutr 1998; 4: 5197–5202.
  • Mattila-Sandholm T: The PROBDEMO project: Demonstration of the Nutritional Functionality of Probiotic Foods. Trends in Food Science & Techn 1999; 10: 385–6.
  • Salminen S: Human studies on probiotics: Aspects of scientific documentation. Scand J Nutr 200 1 ; 45: 8-12
  • Berg RD: Probiotics, prebiotics or conbiotics. Trends in Microbiology. 1998; 6: 89–92.
  • Pathmakanthan S, Meance S, Edwards CA: Probiotics: A review of human studies to date and methodological approaches. Microbial Ecol Health Dis 2000 Suppl 2: 10-30.
  • Crittenden RG: Prebiotics. In: Probiotics: A Critical Review, Horizon Scientific Press, Wymondham, UK 1999; 14 1–56.
  • Brown I, Warhurst J, Arcot M, Playne M, Illman RJ, Topping DL: Fecal numbers of bifidobacteria are higher in pigs fed Bifidobacterium longum with a high amylose cornstarch than with a low amylose cornstarch. J Nutr 1997; 127: 1822–7.
  • Bird AR, Brown, IL, Topping DL: Starches, resistant starches, the gut microflora and human health. Curr Issues Intest Microbiol 2000; 1 :25–37.
  • Brown I, Conway P, Topping D. The health potential of resistant starches in foods. An Australian perspective. Scand J Nutr 2000; 44: 53–8.
  • Conway, PL: Microbial ecology of the human large intestine. In: Macfarlane & Gibson, eds. Human Colonic Microflora, CRC Press 1996;1-24.
  • Cummings JH, Macfarlane GT: The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991; 70: 443–59.
  • Bingham SA: High-meat diets and cancer risk. Proc Nutr Soc 1999; 58: 243–8.
  • Hirayama K, Rafter J: The role of lactic acid bacteria in colon cancer prevention: mechanisitc considerations. Antonie van Leeuwenhoek 1999; 76: 391–4
  • King TS, Ella M, Hunter JO: Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 1187–9.
  • Lisby G, Andersen J, Engbaek K, Binder V: Mycobacterium paratuber-culosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested polymerase chain reaction. Scand J Gastroenterol 1994; 29: 923–9.
  • Topping DL, Bird AR: Foods, nutrients and digestive health. Australian J Nutr Dietetics 1999; 56: 522–42.
  • Isolauri E. Sutas Y. Kankaanpaa P. Arvilommi H. Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(2 Suppl S):444S-450S.
  • Baghurst PA, Baghurst KI, Record SJ: Dietary fibre, non-starch poly-saccharides and resistant starch - a review. Food Australia 1996; 48: S1–S35.
  • Cummings JH, Bingham SA, Heaton KW, Eastwood MA: Fecal wieght, colon cnacer risk and dietary intake of non-starch polysacchairdes (dietary fiber). Gastroenterology 1993; 103: 1783–9.
  • Gibson GR, Beatty ER, Wang X, Cummings HI: Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastro-enterol 1995; 108: 975–82.
  • de Leenheer L, Hoebregs H: Progress in the elucidation of the composition of chicory inulin. Starch 1994; 46: 193–196.
  • Alles MS, Hartemink R, Meyboon S, Harryvan JL, Van Laere KM, Nagengast FM, Hautvast JG: Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer. Am J Clin Nutr 1999; 69: 980–91.
  • Rao AV: Dose-response effects of inulin and oligofructose and intestinal bifidogenesis effects. J Nutr 1999;129(7S):1442S-1445S.
  • Clausen MR, Jorgensen J, Mortensen PB: Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate. Dig Dis Sci 1998; 43: 2696–707.
  • Roberfroid MB, van Loo JAE, Gibson GR. A review of the bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr. 1997; 128: 11–9.
  • Pachenari A: An investigation of the potential of selected strains of Bifidobacterium to colonise the gastrointestinal tract of mice.1997 PhD thesis. University of New South Wales, UNSW Sydney, Australia.
  • Vaughan EE, Heilig HGHJ, Zoetendal EG, Satokari R, Collins JK, Akker-mans ADL, de Vos WM. Molecular approaches to study probiotic bacteria. Trends Food Sci & Technol 1999; 10: 400–04.
  • Kruse HP. Kleessen B. Blaut M: Effects of inulin on faecal bifidobacteria in human subjects. Brit J Nutr. 1999; 82 (5): 375–82.
  • Ballongue J. Schumann. Quignon P: Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol 1997; 32(Suppl 222):41–4.
  • Williams CH, Witherly SA., Buddington RK Influence of dietary neosugar on selected bacterial groups of the human faecal microbiota. Microbial Ecol Health Dis 1994; 7: 91–7.
  • Bouhnik Y. Flourie B. Dagayabensour L. Pochart P. Gramet G. Durand M. Rambaud. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr 1997; 127: 444–8.
  • Bouhnik Y. Flourie B. Riottot M. Bisetti. Gailing ME Guibert A. Bornet F. Rambaud JC: Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy human. Nutr & Cancer. 1996; 26: 21–9.
  • Kleesen B, Sykura B, Zunft H-J, Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity and bowel habit in elderly constipated persons. Am J Clin Nutr 1997; 65: 1397–402.
  • Ito M, Deguchi Y, Miyamouri A, Matsumoto K, Kikuchi H, Matsumoto K, Kobayashi Y, Yajiama T, Kan T. Effects of administration of galactooligo-saccharides on the human faecal microflora, stool weight and abdominal sensation. Microb Ecol Health Dis 1990; 3: 285–92.
  • Terada A, Hara H, Katoaka M, Mitsuoka T: Effect of lactulose on the composition and metabolic activity of the human faecal flora. Microb Ecol Health Dis 1992; 5: 43–50.
  • Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara 1, Mitsuoka T. Effects of soybean oligosaccharides on human faecal microflora. Microb Ecol Health Dis 1990; 3: 293–303.
  • Benno Y, Endo K, Shiragami N, Sayama K, Mitsuoka T: Effects of raffinose intake on human fecal microflora. Bifidobacteria Microflora 1987; 6: 59–63.
  • Letellier A, Messiek S, Lessard L, Quessy S : Assessments of various treatments to reduce carriage of Salmonella in swine. Can J Vet Res 2000; 64: 27–31.
  • Pedersen AB, Sandstrom B, van Amelsvoort JMM: The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr 1997; 78: 215–22.
  • Fiordaliso M, Kok N, Desager JP, Goethals F, Deboyser D, Roberfroid M, Delzenne N: Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins in rats. Lipids 1995; 30: 163–7.
  • Djouzi Z, Andrieux C: Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human faecal flora. Br J Nutr 1997; 78: 313–24.
  • Tortuero F, Fernández E, Ruperez P, Moreno M: Raffinose and lactic acid bacteria influence caeca] fermentation and serum cholesterol in rats. Nutr Res 1997; 17: 41–9.
  • Jackson KG, Taylor GR, Clohessy AM, Williams CM: The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr 1999; 82: 23–30.
  • Davidson MH, Maki KC, Synecki C, Toni SA, Drennan KB: Effects of dietary inulin on serum lipids in men and women with hyperchole-sterolemia. Nutr Res 1998; 18: 503–17.
  • Luo J, Rizkalla SW, Alamowitch C, Boussairi A, Blayo A, Barry J-L, Laffitte A, Guyon F, Bornet FRJ, Slama G: Chronic consumption of short-chain fructoligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr 1996; 63: 939–45.
  • Brommage R, Binacua C, Antille S, Carrie AL: Intestinal calcium absorp-tion in rats is stimulated by dietary lactulose and other resistant sugars. J Nutr 1993; 123: 2186–94.
  • Delzenne N, Aertssens J, Verplaaetse H, Roccaro M, Roberfroid M: Effect of fermentable fructo-oligosaccharides on mineral, nitrogen and energy digestive balance in the rat. Life Sci 1995; 57: 1579–87.
  • Ohta A, Ohruki M, Takiza T, Inaba H, Adachi T, Kimura S: Effects of fructo-oligosaccharides on the absorption of magnesium and calcium by cecectomized rats. Int J Vitain Nutr Res 1994;316–23.
  • Scholz AG, Van Amelsvort JM, Beynen AC: Dietary native resistant starch but not retrograded resistant starch raises magnesium and calcium absorption in rats. J Nutr 1993; 123: 1724–31.
  • Ohta A, Ohtuski M, Baba S, Hirayama M, Adachi T: Comparison of the nutritional effects of fructo-oligosaccharides of different sugar chain lengths in rats. Nutr Res 1998; 18: 109–20.
  • Coudray C, Bellanger C, Castiglia-Delavaud C, Remésy C, Vermorel M, Rayssignuier Y: Effect of soluble or partly soluble dietary fibres supp-lementation on adsorption and balance of calcium, magnesium, iron and zinc in healthy young men. Eur J Clin Nutr 1997; 51: 375–80.
  • van der Heuval EGHM, Schaafsma G, Muys T, nan Dokkum W. Non-digestible oligosaccharides do not interfere with calcium and nonheme-iron absorption in young healthy men. Am J Clin Nutr 1998; 67: 445–51.
  • van der Heuval EGHM, Muys T, van Dokkum W, Schaafsma G: Oligo-fructose stimulates calcium absorption in adolescents. Am J Clin Nutr 1999; 69: 544–8.
  • Luo. L, Van Yperselle M, Rizkalla SW, Rossi F, Bornet, FRJ, Slama G: Consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 2000; 6: 1572–7.
  • Hunter JO. Tuffnell Q. Lee AJ: Controlled trial of oligofructose in the management of irritable bowel syndrome. J Nutr 1999; 129(Suppl 7): 1451S-1453S.
  • Oh MW, Petschow BW, Buddington RK: Evaluation of fructooligo-saccharide supplementation of oral electrolyte solutions for treatment of diarrhoea. Recovery of the intestinal bacteria. Dig Dis Sci 1998; 43: 138–47.
  • Rowland IR, Tanaka R. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with human faecal microflora. J Appl Bacteriol 1993; 74 (6): 667–74.
  • Rowland IR, Bearne CA, Fischer R, Poolzobel BL. The effect of lactulose on DNA damage induced by DMH in the colon of human flora-associated rats. Nutr & Cancer 1996; 26 (1): 37–47.
  • Reddy BS, Hamid R, Rao CV: Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 1997; 18: 1371–4.
  • Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifido-bacterium longum and inulin on gut bacterial metabolism in rats associated with a human faecal microflora. Carcinogenesis 1999;19;281–5.
  • Taper HS, Delzenne NM, Roberfroid MB: Growth inhibition of trans-plantable mouse tumours by non-digestible carbohydrates. Int J Cancer 1997; 71: 1109–112.
  • Pierre F, Perrin P, Champ M, Bornet F, Meflah K, Menanteau J: Short-chain fructo-oligosaccharides reduce the occurrence of colon tumours and develop gut-associated lymphoid tissue in Min mice. Cancer Res 1997; 57: 225–8.
  • Hughes R, Rowland IR. Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis. 2001; 22: 43–7.
  • Fontaine N, Meslin JC, Lory S, Andrieux C. Intestinal mucin distribution in the germ free rat and in the heteroxenic rat harbouring a human bacterial flora: effect of inulin in the diet. Brit .1 Nutr 1996; 75: 881–92.
  • Cassidy MM, Satchithanandam S, Calvert RI, Vahouny GV, Leeds AR. Quantitative and qualitative adaptions in gastrointestinal mucin with dietary fiber feeding. In: Dietary Fiber: Chemistry, Physiology, and Health Effects, Eds Kritchevsky D, Binfield, Anderson JW. Plenum Press, London. 1990;pp67-88.
  • Napoli JEAC, Miller B: Effects of galacto-oligosaccharides on breath hydrogen and gastrointestinal symptoms. Proc Nutr Soc Aust 2000;24.
  • Bouhnik Y, Vahedi K, Achour L, Attar, A, Salfati J, Pochart, P, Marteau P, Flourie B, RambaudJC: Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in humans. J Nutr 1999; 129: 113–6.
  • Anderson AH, Levine AS, Levitt MD: Incomplete absorption of the carbohydrate in all-purpose wheat flour. N Engl J Med 1981; 304: 891–2.
  • Stephen AM: Starch and dietary fibre: their physiological and epide-miological relationships. Can J Physiol Pharmacol 1991; 69: 116–20.
  • EURESTA Euresta Newsletter 1991; 11: 1.
  • Asp NG, van Amelsvoort JMM, Hautvast JGAJ. Nutritional implications of resistant starch. Nutr Res Rev 1996; 9: 1–31.
  • Annison G, Topping DL: Resistant starch: chemical structure vs physio-logical function. Ann Rev Nutr 1994; 14: 297–320.
  • Brown IL, McNaught KJ, Moloney E. Hi-maizeTM: new directions in starch technology and nutrition. Food Aust 1995; 47: 272–5.
  • Sievert D, Pomerantz Y: Enzyme-resistant starch I. Characterisation and evaluation by enzymatic, thermoanalytical and microscopic methods. Cereal Chem 1989; 66: 342–7.
  • Muir JG, Birkett A, Brown I, Jones G, O'Dea K: Food processing and maize variety affects amounts of starch escaping digestion in the small intestine. Amer J Clin Nutr 1995; 61: 792–9.
  • Englyst HN, Kingman SM, Hudson GJ, Cummings JH: Measurement of resistant starch in vitro and in vivo. Br J Nutr 1996; 75: 749–55.
  • Noakes M, Clifton PM, Nestel PJ, Leu RL, McIntosh G: Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. Am J Clin Nutr 1996; 64: 944–51.
  • Topping DL, Warhurst M, Illman RJ, Brown IL, Playne MJ, Bird AR: A high amylose (amylomaize) starch and fructooligosaccharide increase fecal excretion of bifidobacteria in pigs fed live Bifidobacterium longum. Proc Nutr Soc Aust 1997; 21: 134.
  • Brown I, Wang X, Topping DL, Playne MJ, Conway PL: High amylose maize starch as a versatile prebiotic for use with probiotic bacteria. Food Aust 1998; 50: 602–9.
  • Okamoto T. Sasaki M. Tsujikawa T. Fujiyama Y. Bamba. Kusunoki M: Preventive efficacy of butyrate enemas and oral administration of Clostri-dium butyricum M588 in dextran sodium sulfate-induced colitis in rats. J Gastroenterol. 2000; 35 (5): 341–346.
  • Kuroaki T, Iwanaga M, Kobari K, Higashionna A, Kinjyo F, Saito A: Preventive effect of Clostridium butyricum M588 against the proliferation of Clostridium difficile during antimicrobial therapy. J Japanese Assoc Infect Dis 1990; 64: 1425-32.
  • Wang X, Conway PL, Brown IL, Evans AJ: In vitro utilization of amylo-pectin and high amylose maize (amylomaize) starch granules by human colonic bacteria. Appl Environ Microbiol. 1999; 56: 4848–54.
  • Sylvi S, Rumney CJ, Cresci A, Rowland IR. Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with faeces from Italian and UK donors. J Appl Microbiol 1999; 86: 521–30.
  • Kleesen B, Stoof G, Proll J, Schmiedl D, Noack J, Blaut M. Feeding resistant starch affects fecal and cecal microflora and short chain fatty acids in rats. J Anim Sci 1997; 75: 2453–2462.
  • Ramakrishma BS, Venkataraman S, Srinivasan P, Dash P, Young G, Binder HJ:Resistant starch as adjuvant in oral rehydration therapy of cholera in adults. New Engl J Med 2000; 342: 308–13.
  • Treptow-van Lishaut S, Rechkemmer G, Rowland I, Dolara P, Pool-Zobel BL: The carbohydrate crystalean and colonic microflora modulate expression of glutathione S-transferase subunits in colon of rats. Eur J Nutr 1999; 38: 76–83.
  • Hylla S. Gostner A, Dusel G, Anger H, Bartram HP., Cluistl SU, Kasper H, Scheppach W: Effects of resistant starch on the colon in healthy volunteers - possible implications for cancer prevention. Am J Clin Nutr 1998; 67: 136–42.
  • Heijnen MLA, Vanamelsvoort JMM, Deurenberg P, Beynen AC. Limited effect of consumption of uncooked (RS2) or retorgraded (R53) resistant starch on putative risk factors for colon cancer in healthy men. Am J Clin Nutr 1998; 67: 322–31.
  • Ahmed R, Segal I Hassan H: Fermentation of dietary starch in humans. Am J Gastroenterol 95: 1017-20.
  • Cassidy A, Bingham SA, Cummings JH. Starch intake and colorectal cancer risk: an international comparison. Br J Cancer 1994; 69: 937–42.
  • Schulz AGM. Vanamelsvoort JMM. Beynen AC. Dietary native resistant starch but not retrograded resistant starch raises magnesium and calcium absorption in rats. J Nutr 1993; 123: 1724–31.
  • Michel C. Kravtchenko TP. David A. Gueneau S. Kozlowski. Cherbut C: In vitro prebiotic effects of Acacia gums onto the human intestinal microbiota depends on both botanical origin and environmental pH. Anaerobe 1998; 4: 257–66.
  • Parada JL, de Caire GZ, de Mule MCZ, de Cano MMS: Lactic acid bacteria growth promoters from Spirulina platensis. Int J Food Microbiol 1998; 3: 225–8.
  • Terada A, Hara H, Mitsuoka T. Effect of dietary alginate on the faecal microbiota and faecal metabolic activity in humans. Microbiol Ecol Health Dis 1996; 8: 259–66.
  • Ho TKH Effects of yeast glucans on the gastrointestinal microflora of mice. 2000; PhD Thesis, University of New South Wales, UNSW Sydney, Australia.
  • Wang X, Brown IL, Evans AJ, Conway PL: The protective effects of high amylose maize (amylomaize) starch granules on the survival of Bifido-bacterium spp. in the mouse intestinal tract. J Appl Micro 1999; 87: 631–9.
  • Menne E, Guggenbuhl N, Roberfroid M: Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. J Nutr 2000; 5: 1197–9.
  • Govers MJAP. Gannon NJ. Dunshea FR. Gibson PR. Muir JG. Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs. Gut. 1999; 45: 840–7.
  • Reddy BS: Possible mechanisms by which pro- and prebiotics influence carcinogenesis and tumor growth. J Nutr 1999; 129: 1478S-1482S.
  • Perrin S, Grill JP, Schneider F: Effects of fructooligosaccharides and their monomeric components on bile salt resistance in the species of bifidobacteria. J Appl Microbiol 2000; 88: 968–74.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.